Mutant Mouse Core
突变小鼠核心
基本信息
- 批准号:9003078
- 负责人:
- 金额:$ 33.07万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AGTR2 geneAngiotensin II ReceptorAnimal HusbandryAnimalsAreaBreedingBudgetsCardiac MyocytesChickensCore FacilityDuct (organ) structureEP4 receptorEarEpithelialGene TargetingGenerationsGenesGenotypeHypertensionInstitutionInstructionInvestigationKnock-outKnockout MiceLoxP-flanked alleleLuciferasesMaintenanceMouse StrainsMusMutant Strains MiceMutationNOS3 geneOrganOvalbuminPathogenesisPrincipal InvestigatorProstaglandinsReceptor, Angiotensin, Type 1Research PersonnelServicesSodium ChannelSourceSyndromeT-Cell ReceptorTransgenesTransgenic MiceType 2 Angiotensin II ReceptorWFDC2 geneWeaningcollecting tubule structureepithelial Na+ channelexperiencegain of functionhomologous recombinationmouse modelprogramsresearch studyroutine care
项目摘要
The Mutant Mouse Core will centralize effort and provide the expertise necessary to maintain stocks of mice
with various mutations generated by gene targeting and/or transgene insertion for use by participating
investigators. Investigators requiring mice with specific targeted mutations and/or transgenes will be able to
obtain the appropriate genotypes in requisite numbers from the Core. The Core is thus responsible for the
routine care of founder and breeding animals, the husbandry required to generate the experimental animals,
their weaning, application of ear tags for identification, and obtaining genotypes for the relevant gene(s). The
Core is also responsible for supplying suitable controls when they are not readily commercially available.
Breeding programs will be carried out in coordination with each investigator to obtain the appropriate number
of animals of the required genotypes. We will provide the investigators in the PPG renewal the following
gene knockout mice; Angiotensin 1 receptor type l a "floxed" (ATIa-floxed) -/-, angiotensin II receptor type 2
(AT2) -/Y, endothelial nitric oxide synthase (Nos3 or eNOS) -/-, conditional knockouts of the a epithelial
sodium channel (ENaC) in both the cortical collecting duct (CCD) alone and the CCD plus the connecting
tubule (CNT), and cardiac myocyte specific knockout of the prostaglandin EP4 receptor (CS-EP4) -/-. We
will provide the following transgenic mice: NF-KB/luciferase (NF-KB-LUC) Tg, and chicken ovalbumin specific
a and p T-cell receptor (OT II) Tg mice. In addition the Core will provide mice, generated by homologous
recombination, which have a gain-of-function in the PENaC gene as a mouse model of Liddle's syndrome. In
addition the Core will provide the following strains, directly purchased as needed as experimental animals to
PPG investigators; Ragl -/-, p47-/-, NZBWF1/J, and NZW/LacJ.
RELEVANCE (See instructions):
The Mutant Mouse Core of the PPG, Core C will provide genetically modified mice to support the
investigations to be conducted in Projects l-IV, as described in those sections. Providing these core services
will allow the investigators to concentrate on their experiments without having to concern themselves with the
day-to-day husbandry and genotyping of mice.
突变的鼠标核心将集中努力并提供维持小鼠库存所需的专业知识
基因靶向和/或转基因插入产生的各种突变供参与
调查人员。需要具有特定靶向突变和/或转基因的小鼠的调查人员将能够
从核心中获取必要数字的适当基因型。因此,核心负责
创始人和繁殖动物的常规护理,生成实验动物所需的饲养,
它们的断奶,用于识别的ear标签的应用以及获得相关基因的基因型。这
核心还负责提供合适的控件时,当它们不易市售时。
育种计划将与每个研究人员协调,以获取适当的数字
所需基因型的动物。我们将在PPG续约中为调查人员提供以下内容
基因敲除小鼠;血管紧张素1受体型L a“ floxed”(原-氟) - / - ,血管紧张素II受体2型
(AT2) - /Y,内皮一氧化氮合酶(NOS3或ENOS) - / - ,A上皮的条件敲除
单独的皮质收集管(CCD)和CCD加上连接的钠通道(ENAC)
前列腺素EP4受体(CS-EP4)的小管(CNT)和心肌细胞特异性敲除 - / - 。我们
将提供以下转基因小鼠:NF-KB/荧光素酶(NF-KB-LUC)TG和鸡卵形蛋白特异性
A和P T细胞受体(OT II)TG小鼠。此外,核心将提供由同源物产生的小鼠
重组,在PENAC基因中具有功能获得,作为Liddle综合征的小鼠模型。在
核心将提供以下菌株,根据需要直接购买作为实验动物
PPG调查人员; ragl - / - ,p47 - / - ,nzbwf1/j和nzw/lacj。
相关性(请参阅说明):
PPG的突变小鼠核心核心C将提供转基因的小鼠以支持
如这些部分所述,在L-IV项目中进行的调查。提供这些核心服务
将允许调查人员专注于他们的实验,而不必关心
小鼠的日常饲养和基因分型。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
EDWARD G. SHESELY其他文献
EDWARD G. SHESELY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('EDWARD G. SHESELY', 18)}}的其他基金
相似国自然基金
血管紧张素II2型受体在血管损伤中抑制周围脂肪组织功能失调的作用及机制研究
- 批准号:82200458
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
血管紧张素II2型受体在血管损伤中抑制周围脂肪组织功能失调的作用及机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
人个体化急性缺血再灌注损伤大脑保护与修复芯片研究
- 批准号:81901840
- 批准年份:2019
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
骨髓来源的CXCR2阳性单核细胞在高血压性视网膜血管损伤中作用及分子机制
- 批准号:81900880
- 批准年份:2019
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
血管紧张素II1型受体在白血病发病中的功能和机制研究
- 批准号:81970139
- 批准年份:2019
- 资助金额:55 万元
- 项目类别:面上项目
相似海外基金
Short Course: Integrative and Organ Systems Pharmacology
短期课程:综合和器官系统药理学
- 批准号:
7232109 - 财政年份:2005
- 资助金额:
$ 33.07万 - 项目类别: